Overview
Tri Wibawa practices in Yogyakarta, Indonesia. Mr. Wibawa is rated as an Experienced expert by MediFind in the treatment of COVID-19. His top areas of expertise are Junctional Epidermolysis Bullosa, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Epidermolysis Bullosa.
His clinical research consists of co-authoring 45 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of COVID-19.
Locations
Yogyakarta, YO, Indonesia
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Junctional Epidermolysis BullosaMr. Wibawa isAdvanced. Learn about Junctional Epidermolysis Bullosa.
- Experienced
- COVID-19Mr. Wibawa isExperienced. Learn about COVID-19.
- DiarrheaMr. Wibawa isExperienced. Learn about Diarrhea.
- Dystrophic Epidermolysis BullosaMr. Wibawa isExperienced. Learn about Dystrophic Epidermolysis Bullosa.
- Epidermolysis BullosaMr. Wibawa isExperienced. Learn about Epidermolysis Bullosa.
- Severe Acute Respiratory Syndrome (SARS)
- ThrushMr. Wibawa isExperienced. Learn about Thrush.